Defining advanced lymph node metastasis in intrahepatic cholangiocarcinoma: A multicenter study
- PMID: 40317676
- DOI: 10.1111/hepr.14196
Defining advanced lymph node metastasis in intrahepatic cholangiocarcinoma: A multicenter study
Abstract
Background: There is no specific boundary for stratifying survival outcomes in patients with node-positive intrahepatic cholangiocarcinoma (ICC). This study aimed to propose advanced nodal status in ICC.
Methods: Data from patients with pathologically confirmed node-positive ICC who underwent liver resection (LR) with lymph node dissection (LND) from 2000 to 2020 at three tertiary centers were retrospectively analyzed. The boundaries of regions and the yield that stratified overall survival (OS) were evaluated. The lymph node (LN) regions were defined as follows: hepatoduodenal ligament, common hepatic artery, and peripancreatic area (HCP-area), gastrohepatic area (GH-area), and para-aortic area (A-area).
Results: Eighty-four patients with node-positive ICC were enrolled in this study. The median numbers of retrieved LNs and involved LNs (ILNs) were 15 (range: 2-56) and 2 (range: 1-20), respectively. Most patients (96.5%) had ILNs in the HCP-area, whereas only 3 patients (3.5%) had ILNs in other areas without HCP-area involvement. OS of patients with LN metastasis confined to the HCP-area was better than for those beyond this area (median OS: 24.3 vs. 13.3 months, p = 0.047). The best cut-off number of ILNs to stratify OS was 4, and patients with 1-3 ILNs showed better OS than those with ≥ 4 ILNs (25.4 vs. 13.8 months, p = 0.006). Combining distribution and yield showed the best prognostic power compared to using either distribution or yield alone.
Conclusion: In patients with node-positive ICC, LN metastasis beyond the HCP-area or ≥ 4 ILNs can be proposed as advanced N disease.
Keywords: ICC; TNM; lymph node; lymph node dissection.
© 2025 Japan Society of Hepatology.
References
REFERENCES
-
- Alvaro D, Gores GJ, Walicki J, Hassan C, Sapisochin G, Komuta M, et al. EASL‐ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79(1):181–208. https://doi.org/10.1016/j.jhep.2023.03.010
-
- Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–1289. https://doi.org/10.1016/j.jhep.2014.01.021
-
- Yoh T, Hatano E, Yamanaka K, Nishio T, Seo S, Taura K, et al. Is surgical resection justified for advanced intrahepatic cholangiocarcinoma? Liver Cancer. 2016;5(4):280–289. https://doi.org/10.1159/000449339
-
- Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta‐analysis. JAMA Surg. 2014;149(6):565–574. https://doi.org/10.1001/jamasurg.2013.5137
-
- Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
